ERBB2 and breast carcinoma: In human breast cancer, it is known that the cancer can be classified into five molecular subtypes (Luminal A, Luminal B, Basal-like, ErbB2+, and Normal-like), and these classifications have been found to have significant associations with survival and clinical outcomes (51).